Natco Pharma Limited

NATCOPHARMDeep value region

A 6-pillar fundamental profile. Each pillar scored 0–10.

7.8/10 composite
Prism for NATCOPHARM.NS: composite 7.8 of 10, verdict Deep value regionPULSEQUALITYMOATSAFETYGROWTHVALUEn/a0.00.00.00.00.0

Pulse

· Neutral

Pulse data unavailable; neutral placeholder

Pulse tracks recent momentum in price, analyst revisions, and news sentiment. Higher means stronger near-term tailwinds.

Quality

7.7 · Strong

Piotroski 6/9, ROCE 30.0%

Quality captures profitability, return on capital, and earnings consistency. Higher means a better business.

Moat

6.5 · Moderate

Narrow moat

Moat estimates durable competitive advantages — brand, scale, switching costs. Higher means more defensible.

Safety

7.0 · Moderate

Int cov 135.8x

Safety looks at balance-sheet strength, leverage, and cash generation. Higher means lower financial risk.

Growth

8.6 · Strong

Rev CAGR 35.6%

Growth reflects revenue and earnings expansion over recent years. Higher means faster compounding.

Value

10.0 · Strong

MoS 49%

Value measures whether the stock is cheap relative to its intrinsic worth. Higher is cheaper.

Compare with another stock

Overlay NATCOPHARM's prism against a peer.

Share this prism

Get the full analysis

Interactive DCF, sensitivity, peer comparison, and AI summary for NATCOPHARM.

Full analysis →

Model estimate. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.